A member of the firm’s alternative asset opportunities practice, Christian routinely represents some of the world’s largest institutional investors, including sovereign investors, pension funds, secondary buyers, and other large investors, as they deploy capital. He regularly advises clients in connection with a range of transactions around the world and across asset classes, including continuation vehicle transactions, secondary purchases and sales, and other structured liquidity transactions, co-investments, direct investments, and joint ventures.
Clients have told Chambers that Christian “leads us through difficult transactions and always conveys complex issues in a clear and concise manner,” “knows how to manage very complex transactions,” and “is an up-and-coming superstar in the space.”
As part of Ropes & Gray’s secondary buyer practice, which represents 10 of the top 15 secondary buyers globally, Christian has advised lead investors—including co-leads and lead investor syndicates—in some of the largest and most complex continuation vehicle transactions in the market in recent years. In 2024, the Ropes & Gray team closed more than 600 secondaries transactions worth over $275 billion.
Christian also maintains an active pro bono practice, including representing an asylum seeker and his family and case screening review for the Innocence Project.
During law school, Christian served as an executive articles editor of the Boston College Law Review and as a Judiciary Fellow with the U.S. Senate Judiciary Committee’s Subcommittee on Crime & Terrorism in Washington, D.C. Prior to law school, Christian held a number of positions in the Office of the Governor of Rhode Island, his home state, including Chief Speechwriter, Deputy Communications Director, and Special Assistant to the Governor. He also served as campaign coordinator for a successful gubernatorial campaign.
Experience
- Represented the lead investor, co-lead investors or lead investor syndicates in GP-led continuation vehicle transactions ranging from several hundred million to multiple billion dollars, including:
- Three-lead buyer syndicate in a $2.2 billion multi-asset continuation fund transaction.
- Co-lead buyer in a $2.3 billion multi-asset continuation fund transaction.
- Sovereign wealth fund as lead buyer in a $3 billion single-asset recapitalization of a data center business.
- Co-lead buyer in a €2.3 billion multi-asset continuation fund transaction.
- Co-lead buyer in a €2.5 billion multi-asset continuation fund transaction.
- Lead buyers in the $2.75 billion recapitalization of private equity and mezzanine funds.
- Lead buyer in a $1.5 billion multi-asset continuation fund transaction.
- Lead buyers in a $1.3 billion multi-asset continuation fund transaction.
- Lead buyer in a $1.2 billion multi-asset continuation fund transaction.
- Lead buyer in a $830 million single-asset continuation fund transaction.
- European secondary buyer as lead buyer with respect to a $1+ billion acquisition of a portfolio of more than 200 credit and REIT positions from a global insurance company and eight of its client accounts into a continuation fund, as well as the launch of a new credit fund platform, including the warehousing of that fund’s initial portfolio.
- Lead buyer in a $360 million multi-asset continuation fund transaction.
- Lead buyers in the $270 million recapitalization of two Chinese private equity funds.
- Regularly represents secondary buyers and sellers in LP-led secondary purchases and sales, including a secondary buyer in its purchase of a $1.3 billion portfolio of 90+ fund interests from an Asian insurance company.
- Regularly represents sovereign investors and other institutional investors in co-investment transactions. In 2024, the Ropes & Gray team closed over 400 co-investment transactions.
- Advised an Australian sovereign wealth fund on the restructuring of its global venture capital portfolio and an unwinding of related fund structures in a $1.5 billion transaction.
- Represented healthcare-focused manager on formation, fundraise and launch of $2 billion closed-end fund.
- Represented biotech investment firm on formation of biotech impact investment fund.
- Represented private equity sponsor in its investment in integrated healthcare provider.
- Represented private equity sponsor in ongoing portfolio company matters, including corporate governance and general corporate matters.